Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome. (Q37946105)
Jump to navigation
Jump to search
scientific article published on 06 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome. |
scientific article published on 06 October 2011 |
Statements
Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome (English)
Cumali Efe
Ersan Ozaslan
Taylan Kav
Tugrul Purnak
Ozgür Ozkayar
Alexandra Heurgue Berlot
Cenk Sökmensuer